Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The 4-4-2 local anesthetic mix is a specific formulation used for pain management during and after voluntary medical male circumcision (VMMC). Developed and studied at International Hospital Kampala, the mixture consists of 4cc of 2% lidocaine (lignocaine), 4cc of 0.5% bupivacaine, and 2cc of water for injection. Both lidocaine and bupivacaine are small molecule local anesthetics that function as sodium channel blockers, inhibiting the initiation and conduction of nerve impulses to provide regional anesthesia. In clinical research, this specific ratio was evaluated in an observational study to compare its efficacy in postoperative pain control against other concentrations, such as a 3-3-4 mixture, which was found to be superior.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + bupivacaine (4-4-2 ratio).